Finance

Lists
603590:SHA
Beijing Konruns Pharmaceutical Co Ltd
CNÂ¥27,66
-1,28%
(-0,36) 1D
15 Okt., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603590...
Open
CNÂ¥27,36
High
CNÂ¥28,44
Low
CNÂ¥27,33
Mkt. cap
4,71 mjd
Avg. vol.
2,38 m
Volume
3,20 m
Dividend
1,27%
Quarterly dividend
CNÂ¥0,09
Ex-dividend date
08 Jul. 2026
P/E ratio
25,80
52-wk high
CNÂ¥54,86
52-wk low
CNÂ¥27,33
EPS
CNÂ¥1,07
Shares outstanding
160,00 m
No. of employees
793
Open
CNÂ¥27,36
High
CNÂ¥28,44
Low
CNÂ¥27,33
Mkt. cap
4,71 mjd
Avg. vol.
2,38 m
Volume
3,20 m
Dividend
1,27%
Quarterly dividend
CNÂ¥0,09
Ex-dividend date
08 Jul. 2026
P/E ratio
25,80
52-wk high
CNÂ¥54,86
52-wk low
CNÂ¥27,33
EPS
CNÂ¥1,07
Shares outstanding
160,00 m
No. of employees
793
News stories
From web sources and news partners
About Beijing Konruns Pharmaceutical Co Ltd
CEO-
Employees793
Founded03 Sep. 2003
Headquarters-
SectorPharmaceutical industry
Websitekonruns.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
231,35 m
222,90 m
214,87 m
247,93 m
Cost of goods sold
22,91 m
24,09 m
21,90 m
25,26 m
Cost of revenue
22,91 m
24,09 m
21,90 m
25,26 m
Research and development expenses
12,30 m
19,06 m
13,34 m
26,66 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154,66 m
141,77 m
116,52 m
141,17 m
Operating expense
166,20 m
167,04 m
133,22 m
168,99 m
Total operating expenses
189,12 m
191,13 m
155,12 m
194,26 m
Operating income
42,23 m
31,77 m
59,75 m
53,67 m
Other non operating income
-14,51 m
12,12 m
-636,15 k
584,04 k
EBT including unusual items
38,44 m
41,48 m
58,70 m
62,24 m
EBT excluding unusual items
28,50 m
47,88 m
60,43 m
61,01 m
Income tax expense
475,46 k
6,35 m
10,19 m
10,18 m
Effective tax rate
1,24%
15,32%
17,36%
16,36%
Other operating expenses
113,66 k
5,54 m
1,21 m
2,64 m
Net income
36,83 m
38,09 m
47,21 m
48,51 m
Net profit margin
15,92%
17,09%
21,97%
19,57%
Earnings per share
-
-
-
-
Interest and investment income
1,19 m
9,96 m
3,52 m
10,46 m
Interest expense
-2,08 m
-2,13 m
-2,20 m
-2,39 m
Net interest expenses
-889,52 k
7,84 m
1,32 m
8,07 m
Depreciation and amortization charges
-
-
-
-
EBITDA
49,22 m
39,15 m
67,12 m
62,47 m
Gain or loss from assets sale
130,67 k
553,62 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme